Indian pharma & biotech cos confident of new US President Trump's support to Indian pharma

Indian pharma & biotech cos confident of new US President Trump's support to Indian pharma

Indian pharma and biotech companies are confident that under the new US President Donald Trump, its strengths in high quality generics manufacture and export will continue to command respect. This view is based on the fact that when Donald Trump became the US President his government continued a favourable relationship, particularly recognizing India's role in global drug production.

US remains a powerhouse in pharmaceutical research and development. With a robust infrastructure, significant investment in biotechnology and pharmaceutical companies, along with a supportive regulatory environment, the US continues to lead the way in bringing new drugs and therapies to market. Further, the presence of leading research institutions, academic centres, and pharmaceutical companies contribute to this leadership position.

Furthermore US pharmaceutical market is not only about innovation but also provides a thriving generic drug market. Generic drugs offer cost-effective alternatives to brand-name medications, helping to reduce healthcare expenses for patients. This presents significant opportunities for Indian pharma to trade in the US, amid concerns about rising healthcare costs, said the industry.

Overall, the US-India pharmaceutical relationship is mutually beneficial. India is playing a key role in supplying affordable medications and the US providing an attractive market with a stringent regulatory environment for companies to prove their mettle. The partnership will continue to evolve with advancements in drug development and manufacturing technology, said the industry observers.

Harish K Jain, president, Federation of Pharmaceutical Entrepreneurs (FOPE) and director, Embiotic Labs, India is known as the ‘pharmacy of the world’ because it is a leading supplier of generic drugs, which are essential for affordable healthcare worldwide.

 The country produces a wide range of medications, from basic generics to complex formulations, and is especially prominent in producing generic versions of high-cost branded drugs. According to some estimates, Indian manufacturers provide approximately 40-50% of all generic drugs used in the US market.

If you are a fresher in the Export field.

????Join our Startup Export Training. 

For more details.

???? Visit www.ucorpexim.in or Contact 7598 404848

If you have basic about the Export field

????Join our Advanced Realtime Export Training.

For more details.

????Visit www.ucorpareto.com or Contact 7598 786858

#export #exporter #exportimport #exports #importexport #exportproduct #exportbusiness #exportbag #exportquality #exportindia #exporting #exportimportdata #eximedia #indiaexport #indiaexports #indiaexporters #indiaexportimport #indiabusiness #ucorpexim #exporttraining#exportstraining #exportertraining #exporterstraining #importtraining #importstraining #importertraining #importerstraining #ucorp